FOX Business’ Lydia Hu reports on the latest news emerging from the pharmaceutical industry as the U.S.’ medication shortage reaches a new record.
On Thursday, Pfizer announced plans to advance its weight-loss pill after “encouraging” results from an early-stage study.
The pharmaceutical giant is trying to tap into the highly lucrative market for obesity drugs currently dominated by the likes of Eli Lilly and Novo Nordisk.
HIMS & HERS ROLLS OUT WEIGHT-LOSS SHOTS MUCH CHEAPER THAN OZEMPIC, WEGOVY
Pfizer said it has a “robust pipeline” of three clinical and several other pre-clinical candidates but that danuglipron, a once-a-day oral treatment, was “the most advanced of them.”
The company plans to conduct tests later this year to determine the ideal dose of the drug.
The Pfizer logo on the company headquarters building in New York City. (REUTERS/Carlo Allegri /…
